Symbols / AFIB $0.00 +0.00% Acutus Medical, Inc.

Healthcare • Medical Devices • United States • PNK
AFIB Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Takeo Mukai
Exch · Country PNK · United States
Market Cap 2.99K
Enterprise Value 21.75M
Income -4.54M
Sales 20.16M
FCF (ttm) -6.78M
Book/sh -0.39
Cash/sh 0.47
Employees 85
Insider 10d —
IPO Aug 06, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.00
PEG —
P/S 0.00
P/B -0.00
P/C —
EV/EBITDA -2.38
EV/Sales 1.08
Quick Ratio 1.61
Current Ratio 2.06
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -0.15
EPS next Y -2.19
EPS Growth —
Revenue Growth 203.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2023-11-08
Earnings (prior) 2023-11-08
ROA -14.26%
ROE —
ROIC —
Gross Margin 5.03%
Oper. Margin -21.75%
Profit Margin -47.36%
Shs Outstand 29.91M
Shs Float 24.78M
Insider Own 8.29%
Instit Own 8.85%
Short Float 1.91%
Short Ratio 0.68
Short Interest 553.60K
52W High 0.01
vs 52W High -99.29%
52W Low 0.00
vs 52W Low 0.00%
Beta 5.75
Impl. Vol. —
Rel Volume 2.05
Avg Volume 4.89K
Volume 10.00K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.00
Price $0.00
Change 0.00%
About

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-4.08
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2022-08-16 main Goldman Sachs — → Neutral $2
2022-06-24 main BTIG — → Buy $2
2022-04-27 up BTIG Neutral → Buy $2
2022-04-14 main Goldman Sachs — → Neutral $1
2022-01-20 down BTIG Buy → Neutral —
2022-01-14 down Canaccord Genuity Buy → Hold $3
2021-11-12 down JP Morgan Neutral → Underweight —
2021-11-12 main Canaccord Genuity — → Buy $10
2021-10-22 init Goldman Sachs — → Neutral $10
2021-07-15 up Canaccord Genuity Hold → Buy $18
2021-03-19 main Canaccord Genuity — → Hold $16
2021-03-19 down William Blair Outperform → Market Perform —
2021-03-19 down JP Morgan Overweight → Neutral $19
2021-01-14 down B of A Securities Buy → Neutral —
2020-08-31 init William Blair — → Outperform —
2020-08-31 init Canaccord Genuity — → Hold $30
2020-08-31 init B of A Securities — → Buy $38
2020-08-31 init JP Morgan — → Overweight $39
News
RSS: Latest AFIB news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
20.16
+181.37%
7.16
+136.36%
3.03
-82.44%
17.26
Operating Revenue
20.16
+181.37%
7.16
+136.36%
3.03
-82.44%
17.26
Cost Of Revenue
19.14
+85.85%
10.30
+108.48%
4.94
-84.99%
32.92
Reconciled Cost Of Revenue
19.14
+85.85%
10.30
+108.48%
4.94
-84.99%
32.92
Gross Profit
1.01
+132.29%
-3.14
-64.24%
-1.91
+87.80%
-15.66
Operating Expense
10.44
-40.53%
17.55
-25.11%
23.43
-76.62%
100.21
Research And Development
0.00
-100.00%
3.48
+11.67%
3.12
-91.50%
36.68
Selling General And Administration
10.44
-25.81%
14.07
-30.76%
20.32
-68.02%
63.52
Total Expenses
29.58
+6.22%
27.85
-1.85%
28.37
-78.69%
133.13
Operating Income
-9.42
+54.45%
-20.68
+18.38%
-25.34
+78.13%
-115.87
Total Operating Income As Reported
-0.06
+99.51%
-11.73
-128.57%
41.04
+136.61%
-112.12
EBITDA
2.25
+142.20%
-5.33
-115.14%
35.20
+133.49%
-105.12
Normalized EBITDA
-7.33
+57.43%
-17.22
+25.98%
-23.27
+78.63%
-108.86
Reconciled Depreciation
1.03
+17.51%
0.87
-27.65%
1.21
-82.47%
6.89
EBIT
1.22
+119.70%
-6.20
-118.25%
34.00
+130.35%
-112.01
Total Unusual Items
9.58
-19.45%
11.89
-79.66%
58.47
+1460.92%
3.75
Total Unusual Items Excluding Goodwill
9.58
-19.45%
11.89
-79.66%
58.47
+1460.92%
3.75
Special Income Charges
9.37
+4.57%
8.96
-84.67%
58.44
+1460.04%
3.75
Other Special Charges
—
—
7.95
—
Impairment Of Capital Assets
—
0.00
-100.00%
12.03
0.00
Restructuring And Mergern Acquisition
1.45
+1077.24%
0.12
-88.32%
1.05
+128.11%
-3.75
Net Income
-9.55
+88.31%
-81.66
-106.14%
-39.62
+66.34%
-117.68
Pretax Income
-4.54
+61.75%
-11.86
-141.11%
28.85
+124.51%
-117.68
Net Non Operating Interest Income Expense
-5.00
-62.86%
-3.07
+28.36%
-4.28
+23.02%
-5.56
Interest Expense Non Operating
5.76
+1.82%
5.66
+9.83%
5.15
-9.30%
5.68
Net Interest Income
-5.00
-62.86%
-3.07
+28.36%
-4.28
+23.02%
-5.56
Interest Expense
5.76
+1.82%
5.66
+9.83%
5.15
-9.30%
5.68
Interest Income Non Operating
0.76
-70.52%
2.59
+198.16%
0.87
+648.28%
0.12
Interest Income
0.76
-70.52%
2.59
+198.16%
0.87
+648.28%
0.12
Other Income Expense
9.88
-16.92%
11.89
-79.66%
58.47
+1460.92%
3.75
Other Non Operating Income Expenses
0.30
—
—
—
Gain On Sale Of Security
0.21
-92.68%
2.94
+8800.00%
0.03
—
Gain On Sale Of Business
10.81
+19.10%
9.08
-88.57%
79.47
0.00
Tax Provision
0.00
-100.00%
0.06
+320.00%
0.01
0.00
Tax Rate For Calcs
0.00
-100.00%
0.00
+40284.62%
0.00
0.00
Tax Effect Of Unusual Items
0.00
-100.00%
2.50
+8115.31%
0.03
0.00
Net Income Including Noncontrolling Interests
-9.55
+88.31%
-81.66
-106.14%
-39.62
+66.34%
-117.68
Net Income From Continuing Operation Net Minority Interest
-4.54
+61.95%
-11.92
-141.34%
28.83
+124.50%
-117.68
Net Income From Continuing And Discontinued Operation
-9.55
+88.31%
-81.66
-106.14%
-39.62
+66.34%
-117.68
Net Income Continuous Operations
-4.54
+61.95%
-11.92
-141.34%
28.83
+124.50%
-117.68
Net Income Discontinuous Operations
-5.01
+92.81%
-69.74
-1.89%
-68.45
—
Normalized Income
-14.12
+33.78%
-21.32
+28.00%
-29.61
+75.62%
-121.43
Net Income Common Stockholders
-9.55
+88.31%
-81.66
-106.14%
-39.62
+66.34%
-117.68
Diluted EPS
—
-2.81
-100.71%
-1.40
+65.94%
-4.11
Basic EPS
—
-2.81
-100.71%
-1.40
+65.94%
-4.11
Basic Average Shares
—
29.10
+2.73%
28.32
-1.16%
28.65
Diluted Average Shares
—
29.10
+2.73%
28.32
-1.16%
28.65
Diluted NI Availto Com Stockholders
-9.55
+88.31%
-81.66
-106.14%
-39.62
+66.34%
-117.68
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
28.65
-46.91%
53.96
-59.56%
133.44
-21.41%
169.79
Current Assets
25.58
-44.70%
46.25
-60.76%
117.87
-6.67%
126.29
Cash Cash Equivalents And Short Term Investments
14.02
-37.42%
22.40
-68.20%
70.45
-30.09%
100.77
Cash And Cash Equivalents
14.02
-26.87%
19.17
-25.07%
25.58
+6.29%
24.07
Other Short Term Investments
0.00
-100.00%
3.23
-92.79%
44.86
-41.51%
76.70
Receivables
7.88
-30.61%
11.35
-49.81%
22.62
+522.68%
3.63
Accounts Receivable
7.88
-30.61%
11.35
-36.64%
17.92
+393.23%
3.63
Other Receivables
—
—
4.70
—
Inventory
1.79
-58.16%
4.28
+138.46%
1.79
-89.07%
16.41
Raw Materials
1.19
-65.40%
3.43
+290.43%
0.88
-87.05%
6.78
Work In Process
0.58
+82.76%
0.32
+61.93%
0.20
-88.88%
1.77
Finished Goods
0.02
-96.05%
0.53
-26.15%
0.72
-90.85%
7.86
Prepaid Assets
—
—
—
5.33
Restricted Cash
0.00
-100.00%
7.03
+21.96%
5.76
+3742.67%
0.15
Assets Held For Sale Current
1.25
+145.10%
0.51
-96.81%
15.99
—
Other Current Assets
0.64
-5.46%
0.68
-45.93%
1.25
-76.46%
5.33
Total Non Current Assets
3.07
-60.17%
7.71
-50.50%
15.57
-64.20%
43.50
Net PPE
2.98
-25.86%
4.01
-27.56%
5.54
-69.54%
18.19
Gross PPE
6.69
-12.39%
7.64
-14.15%
8.90
-70.43%
30.09
Accumulated Depreciation
-3.72
-2.54%
-3.62
-7.99%
-3.36
+71.80%
-11.90
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
3.24
-6.35%
3.46
-0.06%
3.46
-52.36%
7.27
Construction In Progress
0.04
+485.71%
0.01
-99.29%
0.98
+2.30%
0.96
Other Properties
2.46
-22.89%
3.19
-17.64%
3.87
-81.80%
21.28
Leases
0.95
-3.06%
0.98
+68.79%
0.58
-0.34%
0.58
Goodwill And Other Intangible Assets
—
—
1.58
-90.71%
17.04
Goodwill
—
—
0.00
-100.00%
12.03
Other Intangible Assets
—
—
1.58
-68.42%
5.01
Investments And Advances
—
—
0.00
-100.00%
7.12
Other Non Current Assets
0.09
-97.46%
3.69
-63.18%
10.03
+770.83%
1.15
Total Liabilities Net Minority Interest
40.24
-26.62%
54.84
-6.13%
58.42
-8.81%
64.07
Current Liabilities
12.44
-34.34%
18.94
-4.68%
19.87
+7.36%
18.51
Payables And Accrued Expenses
3.30
-3.62%
3.42
+2.18%
3.35
-63.29%
9.13
Payables
1.28
-53.78%
2.76
+4.03%
2.65
-65.03%
7.59
Accounts Payable
1.28
-53.78%
2.76
+11.65%
2.47
-67.11%
7.52
Current Accrued Expenses
2.02
+205.59%
0.66
-4.89%
0.70
-54.69%
1.54
Pensionand Other Post Retirement Benefit Plans Current
0.98
-55.82%
2.23
-8.55%
2.43
-65.67%
7.09
Total Tax Payable
—
0.00
-100.00%
0.18
+154.93%
0.07
Current Debt And Capital Lease Obligation
7.96
+208.37%
2.58
+709.40%
0.32
-19.24%
0.40
Current Debt
7.00
+275.80%
1.86
—
—
Other Current Borrowings
7.00
+275.80%
1.86
—
—
Current Capital Lease Obligation
0.96
+33.29%
0.72
+125.08%
0.32
-19.24%
0.40
Current Deferred Liabilities
—
—
0.33
-18.70%
0.40
Current Deferred Revenue
—
—
0.33
-18.70%
0.40
Other Current Liabilities
0.19
-98.19%
10.71
-22.21%
13.77
+818.00%
1.50
Total Non Current Liabilities Net Minority Interest
27.80
-22.55%
35.90
-6.88%
38.55
-15.38%
45.56
Long Term Debt And Capital Lease Obligation
27.80
-22.55%
35.90
-6.85%
38.54
-14.37%
45.01
Long Term Debt
25.56
-21.71%
32.65
-5.17%
34.43
-14.80%
40.41
Long Term Capital Lease Obligation
2.24
-30.99%
3.24
-20.96%
4.10
-10.63%
4.59
Other Non Current Liabilities
—
—
0.01
-97.82%
0.55
Stockholders Equity
-11.59
-1218.77%
-0.88
-101.17%
75.02
-29.04%
105.73
Common Stock Equity
-11.59
-1218.77%
-0.88
-101.17%
75.02
-29.04%
105.73
Capital Stock
0.03
+3.45%
0.03
+0.00%
0.03
+3.57%
0.03
Common Stock
0.03
+3.45%
0.03
+0.00%
0.03
+3.57%
0.03
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
29.91
+2.04%
29.31
+2.66%
28.55
+2.14%
27.96
Ordinary Shares Number
29.91
+2.04%
29.31
+2.66%
28.55
+2.14%
27.96
Additional Paid In Capital
598.67
-0.21%
599.93
+0.97%
594.17
+1.64%
584.61
Retained Earnings
-609.52
-1.59%
-599.98
-15.76%
-518.31
-8.28%
-478.70
Gains Losses Not Affecting Retained Earnings
-0.77
+11.32%
-0.87
+0.35%
-0.87
-300.46%
-0.22
Other Equity Adjustments
-0.77
+11.32%
-0.87
+0.35%
-0.87
-300.46%
-0.22
Total Equity Gross Minority Interest
-11.59
-1218.77%
-0.88
-101.17%
75.02
-29.04%
105.73
Total Capitalization
13.97
-56.03%
31.77
-70.97%
109.45
-25.10%
146.14
Working Capital
13.14
-51.89%
27.31
-72.13%
98.00
-9.08%
107.78
Invested Capital
20.98
-37.64%
33.64
-69.27%
109.45
-25.10%
146.14
Total Debt
35.76
-7.06%
38.48
-0.97%
38.86
-14.42%
45.40
Net Debt
18.55
+20.86%
15.35
+73.42%
8.85
-45.85%
16.34
Capital Lease Obligations
3.19
-19.34%
3.96
-10.43%
4.42
-11.31%
4.99
Net Tangible Assets
-11.59
-1218.77%
-0.88
-101.17%
75.02
-15.41%
88.69
Tangible Book Value
-11.59
-1218.77%
-0.88
-101.17%
75.02
-15.41%
88.69
Available For Sale Securities
—
—
—
7.12
Investmentin Financial Assets
—
—
0.00
-100.00%
7.12
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-31.66
+49.84%
-63.12
+29.01%
-88.92
+10.80%
-99.68
Cash Flow From Continuing Operating Activities
-17.18
+13.43%
-19.85
+35.65%
-30.85
+69.06%
-99.68
Cash From Discontinued Operating Activities
-14.47
+66.55%
-43.27
+25.49%
-58.07
—
Net Income From Continuing Operations
-4.54
+61.95%
-11.92
+69.91%
-39.62
+66.34%
-117.68
Depreciation Amortization Depletion
1.03
+17.51%
0.87
-27.65%
1.21
-82.47%
6.89
Depreciation
1.03
+17.51%
0.87
-11.54%
0.99
-84.19%
6.25
Amortization Cash Flow
—
0.00
-100.00%
0.22
-65.63%
0.64
Depreciation And Amortization
1.03
+17.51%
0.87
-27.65%
1.21
-82.47%
6.89
Amortization Of Intangibles
—
0.00
-100.00%
0.22
-65.63%
0.64
Other Non Cash Items
0.93
+34.15%
0.69
-98.95%
66.33
+41553.13%
-0.16
Stock Based Compensation
0.46
-84.86%
3.03
-10.82%
3.40
-75.28%
13.75
Asset Impairment Charge
—
0.00
-100.00%
12.03
0.00
Operating Gains Losses
-11.03
+8.22%
-12.02
+83.20%
-71.55
-255639.29%
0.03
Gain Loss On Investment Securities
-0.21
+92.68%
-2.94
-8800.00%
-0.03
—
Gain Loss On Sale Of PPE
—
0.00
0.00
-100.00%
0.03
Change In Working Capital
-4.01
-537.66%
0.92
+135.04%
-2.61
+30.99%
-3.79
Change In Receivables
-4.05
-211.55%
3.63
+170.23%
-5.17
-250.78%
-1.47
Changes In Account Receivables
-4.05
-276.91%
-1.07
-131.47%
-0.46
+68.50%
-1.47
Change In Inventory
2.49
+200.16%
-2.48
-3721.54%
-0.07
+98.32%
-3.87
Change In Prepaid Assets
0.05
-92.68%
0.66
-73.25%
2.45
+116.42%
1.13
Change In Payables And Accrued Expense
-1.73
-320.15%
-0.41
-133.50%
1.23
+81.42%
0.68
Change In Accrued Expense
-0.25
+64.86%
-0.70
-148.81%
1.43
-7.42%
1.55
Change In Payable
-1.49
-615.63%
0.29
+241.18%
-0.20
+76.58%
-0.87
Change In Account Payable
-1.49
-615.63%
0.29
+241.18%
-0.20
+76.58%
-0.87
Change In Other Current Assets
—
0.00
0.00
-100.00%
0.30
Change In Other Current Liabilities
-0.77
-61.95%
-0.47
+55.55%
-1.06
-90.68%
-0.56
Investing Cash Flow
22.15
-62.17%
58.55
-44.10%
104.75
+449.41%
19.07
Cash Flow From Continuing Investing Activities
21.81
-63.51%
59.77
-44.92%
108.50
+469.10%
19.07
Cash From Discontinued Investing Activities
0.34
+127.99%
-1.21
+67.74%
-3.75
—
Net PPE Purchase And Sale
-0.11
+48.86%
-0.22
+3.95%
-0.23
+97.71%
-9.97
Purchase Of PPE
-0.11
+48.86%
-0.22
+3.95%
-0.23
+97.71%
-9.97
Capital Expenditure
-0.11
+48.86%
-0.22
+3.95%
-0.23
+97.71%
-9.97
Net Investment Purchase And Sale
3.25
-92.44%
42.98
+10.98%
38.73
+33.38%
29.04
Purchase Of Investment
0.00
+100.00%
-39.77
+27.05%
-54.51
+37.53%
-87.26
Sale Of Investment
3.25
-96.07%
82.75
-11.25%
93.24
-19.83%
116.30
Net Business Purchase And Sale
18.67
+9.84%
17.00
-75.71%
70.00
0.00
Gain Loss On Sale Of Business
-10.81
-19.10%
-9.08
+88.57%
-79.47
0.00
Financing Cash Flow
-2.89
-8.52%
-2.66
+77.07%
-11.62
-114.60%
79.57
Cash Flow From Continuing Financing Activities
-2.85
-19.55%
-2.38
+79.48%
-11.62
-114.60%
79.57
Net Issuance Payments Of Debt
-2.62
0.00
+100.00%
-9.72
0.00
Issuance Of Debt
—
0.00
-100.00%
34.83
0.00
Repayment Of Debt
-2.62
0.00
+100.00%
-44.55
0.00
Long Term Debt Issuance
—
0.00
-100.00%
34.83
0.00
Long Term Debt Payments
-2.62
0.00
+100.00%
-44.55
0.00
Net Long Term Debt Issuance
-2.62
0.00
+100.00%
-9.72
0.00
Net Common Stock Issuance
—
0.00
+100.00%
-0.11
-100.13%
82.66
Common Stock Payments
—
0.00
+100.00%
-0.11
0.00
Repurchase Of Capital Stock
—
0.00
+100.00%
-0.11
0.00
Proceeds From Stock Option Exercised
0.00
-100.00%
0.03
-89.68%
0.28
-75.59%
1.15
Net Other Financing Charges
-0.23
+90.68%
-2.41
-17.08%
-2.06
+51.38%
-4.24
Changes In Cash
-12.40
-71.61%
-7.23
-271.34%
4.22
+502.87%
-1.05
Effect Of Exchange Rate Changes
0.22
-89.37%
2.08
-28.53%
2.91
+2607.76%
-0.12
Beginning Cash Position
26.20
-16.42%
31.35
+29.42%
24.22
-4.58%
25.38
End Cash Position
14.02
-46.49%
26.20
-16.42%
31.35
+29.42%
24.22
Free Cash Flow
-31.77
+49.84%
-63.34
+28.95%
-89.14
+18.70%
-109.66
Interest Paid Supplemental Data
4.54
-9.34%
5.01
+18.46%
4.23
-0.66%
4.26
Amortization Of Securities
-0.03
+98.04%
-1.43
-5850.00%
-0.02
-101.88%
1.28
Common Stock Issuance
—
—
0.00
-100.00%
82.66
Issuance Of Capital Stock
—
—
0.00
-100.00%
82.66
Sale Of Business
18.67
+9.84%
17.00
-75.71%
70.00
0.00
Cash From Discontinued Financing Activities
-0.04
+85.36%
-0.28
0.00
—
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category